The main purpose of this legislation is to allow patients with life-threatening diseases or severely debilitating illnesses to access investigational individualized medical treatments. These treatments are not yet fully approved by regulatory authorities but may offer hope when conventional therapies have failed. The law aims to provide patients with more options for care in critical situations. Key provisions of the law include defining who qualifies as an "eligible patient" and outlining the process for accessing these treatments.